10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001513160-14-000039`
Period End Date	20140630
Filing Date	20140808
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	gnpb-20140630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 48 Cash Flow Statement 46 Stockholders Equity 8

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$18.44M	USD	Point-in-time
Cash and cash equivalents	`Cash`	$19.67M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.00K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$33.73K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$9.74K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$15.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$69.47K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$158.72K	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock Par Value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.85M	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$18.52M	USD	Point-in-time
Preferred Stock Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $33,730 and $16,002	`PropertyPlantAndEquipmentNet`	$15.77K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $33,730 and $16,002	`PropertyPlantAndEquipmentNet`	$27.76K	USD	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	5,800.00	shares	Point-in-time
Preferred Stock Issued	`PreferredStockSharesIssued`	17,000.00	shares	Point-in-time
Total assets	`Assets`	$19.87M	USD	Point-in-time
Total assets	`Assets`	$18.54M	USD	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	5,800.00	shares	Point-in-time
Preferred Stock Outstanding	`PreferredStockSharesOutstanding`	17,000.00	shares	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$440.55K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$412.98K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	20.02M	shares	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	27.23M	shares	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.86M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$715.92K	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	27.23M	shares	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.16M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.27M	USD	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	20.02M	shares	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized,5,800 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$6.00	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized,5,800 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$17.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized,27,226,350 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$1.14K	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized,27,226,350 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$835.00	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$81.88M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$86.03M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.53M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-68.90M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$17.38M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$17.60M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$18.54M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$19.87M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	2 Qtrs
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Revenues	`SalesRevenueGoodsNet`	-	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$1.78M	USD	2 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$87.39K	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$919.35K	USD	1 Quarter
Share-Based Compensation	`ShareBasedCompensation`	$133.03K	USD	2 Qtrs
Operating expenses (including $919,350, $87,386, $1,781,355 and $133,032 in share based compensation costs)	`OperatingCostsAndExpenses`	$779.26K	USD	1 Quarter
Operating expenses (including $919,350, $87,386, $1,781,355 and $133,032 in share based compensation costs)	`OperatingCostsAndExpenses`	$1.75M	USD	1 Quarter
Operating expenses (including $919,350, $87,386, $1,781,355 and $133,032 in share based compensation costs)	`OperatingCostsAndExpenses`	$1.21M	USD	2 Qtrs
Operating expenses (including $919,350, $87,386, $1,781,355 and $133,032 in share based compensation costs)	`OperatingCostsAndExpenses`	$3.71M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$663.89K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$361.23K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$250.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$520.00K	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$4.37M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.73M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$1.03M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-4.37M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.03M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-1.73M	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	2 Qtrs
Interest expense	`InterestExpense`	$445.74K	USD	2 Qtrs
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$104.13K	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	2 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	2 Qtrs
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	1 Quarter
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	1 Quarter
Total other expense	`OtherNonoperatingIncomeExpense`	-	USD	2 Qtrs
Total other expense	`OtherNonoperatingIncomeExpense`	$-2.40M	USD	1 Quarter
Total other expense	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Total other expense	`OtherNonoperatingIncomeExpense`	$-2.74M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.48M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-3.43M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-4.19	USD	1 Quarter
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-1.54	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.19	USD	2 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	22.50M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	818,806.00	shares	1 Quarter
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	2.90M	shares	2 Qtrs
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.14M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-2.11M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.48M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.43M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-4.37M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$17.73K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.11K	USD	2 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.34M	USD	2 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$220.42K	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	2 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$440.75K	USD	2 Qtrs
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	$122.73K	USD	2 Qtrs
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	-	USD	2 Qtrs
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	-	USD	2 Qtrs
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	2 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.86K	USD	2 Qtrs
Deposits, prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-94.51K	USD	2 Qtrs
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$976.32K	USD	2 Qtrs
Accounts payable, accrued expenses and other current liabilities	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-1.11M	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-981.93K	USD	2 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.59M	USD	2 Qtrs
Purchases of computer equipment and furniture	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.74K	USD	2 Qtrs
Purchases of computer equipment and furniture	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.74K	USD	2 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$311.50K	USD	2 Qtrs
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	-	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of warrants	`ProceedsFromIssuanceOfCommonStockUponConversionOfWarrants`	$2.36M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$1.24M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$2.36M	USD	2 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.55M	USD	2 Qtrs
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.23M	USD	2 Qtrs
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$569.58K	USD	2 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$569.58K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.44M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$569.58K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.44M	USD	Point-in-time
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	$9.27M	USD	2 Qtrs
Common stock issued upon conversion of accrued interest and penalty	`CommonStockIssuedUponConversionOfAccruedInterestAndPenalty`	-	USD	2 Qtrs
Common stock issued upon conversion of preferred stock	`CommonStockIssuedUponConversionOfPreferredStock`	$233.00	USD	2 Qtrs
Common stock issued upon conversion of preferred stock	`CommonStockIssuedUponConversionOfPreferredStock`	-	USD	2 Qtrs

Stockholders Equity 8 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquity`	$17.38M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time
Fair value of stock options	`FairValueOfStockOptions`	$1.34M	USD	2 Qtrs
Common stock issued upon exercise of warrants, Amount	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$2.36M	USD	2 Qtrs
Common stock issued for services, Amount	`StockIssuedDuringPeriodValueIssuedForServices`	$440.75K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.37M	USD	2 Qtrs
Ending Balance, Amount	`StockholdersEquity`	$17.38M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquity`	$17.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.